Stay updated on AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial
Sign up to get notified when there's something new on the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page.

Latest updates to the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed descriptions of a clinical study on AGI-134, which included information on its phases, safety, and tolerability. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference37%
- Check30 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of 2025-03-25 while adding two new dates: 2025-01-23 and 2025-02-14.SummaryDifference0.7%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check80 days agoChange DetectedThe webpage has been updated to include detailed information about the AGI-134 study, including its design, dosing regimen, and safety assessments, while removing some previous descriptions and dates related to the study's results and protocols.SummaryDifference34%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page.